Trials / Completed
CompletedNCT02247232
Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer
Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer - A Phase III Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 793 (actual)
- Sponsor
- Zeria Pharmaceutical · Industry
- Sex
- Female
- Age
- 21 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase III, multicenter, double-blind, placebo-controlled, parallel group comparative study to evaluate the efficacy and safety of Z-100 with primary uterine cervical cancer on radiotherapy. The study will use a central randomization with a dynamic allocation using biased coin minimization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Z-100 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2021-06-29
- Completion
- 2022-02-25
- First posted
- 2014-09-23
- Last updated
- 2022-03-04
Locations
7 sites across 7 countries: Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand, Vietnam
Source: ClinicalTrials.gov record NCT02247232. Inclusion in this directory is not an endorsement.